|
|
Office Locations:
|
c/o Pappas Capital P. O. Box 110287RTP
Research Triangle Park, NC 27709
Phone: 919-998-3300
Fax: 919-998-3301
| |
|
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
Chiesi Ventures is an early-stage venture capital firm focused on the area of rare and orphan disorders. Investment focus is on small molecules and biologics, advanced therapies, reformulation technological platforms and devices, and disease discovery, diagnosis and management. The firm aims to accelerate the expansion of the Chiesi network in EU and the US among universities, venture capital investors, rare disease patient organizations and entrepreneurial companies developing treatments for rare diseases. The firm will invest $4M to $5M and reserves a portion of their fund for future rounds. On September 2, 2014, Chiesi Ventures and Pappas Capital announced a strategic collaboration. With the deal, Chiesi Ventures is able to leverage A. M. Pappas & Associates' expertise and network to access and assess deals and opportunities, lead investments and manage transactions.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
